Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.
Schmidinger M, Pichler R, Loidl W, Bauernhofer T, Kretz M, Tinchon C, Niedersüß-Beke D, Pfleger G, Wiesinger CG, Vogl U, Mitterberger M, Stöger H, Tulchiner G, Kratochvill F, Gerritsmann H, Mraz B, Marszalek M. Schmidinger M, et al. Among authors: bauernhofer t. Clin Genitourin Cancer. 2019 Oct;17(5):e957-e967. doi: 10.1016/j.clgc.2019.05.017. Epub 2019 May 25. Clin Genitourin Cancer. 2019. PMID: 31235275 Free article.
Consequences of somatic mutations of GIRK1 detected in primary malign tumors on expression and function of G-protein activated, inwardly rectifying, K+ channels.
Pelzmann B, Hatab A, Scheruebel S, Langthaler S, Rienmueller T, Sokolowski A, Gorischek A, Platzer D, Zorn-Pauly K, Jahn SW, Bauernhofer T, Schreibmayer W. Pelzmann B, et al. Among authors: bauernhofer t. Front Oncol. 2022 Oct 31;12:998907. doi: 10.3389/fonc.2022.998907. eCollection 2022. Front Oncol. 2022. PMID: 36483038 Free PMC article.
A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
Stöger H, Bauernhofer T, Schmid M, Ploner F, Moser R, Derstvenscheg E, Steindorfer P, Wilders-Truschnig M, Kuss I, Samonigg H. Stöger H, et al. Among authors: bauernhofer t. Cancer Chemother Pharmacol. 1994;35(2):174-8. doi: 10.1007/BF00686643. Cancer Chemother Pharmacol. 1994. PMID: 7987997 Clinical Trial.
Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study.
Stöger H, Bauernhofer T, Kasparek AK, Schmid M, Moser R, Ploner F, Derstvenscheg E, Kuss I, Wilders-Truschnig M, Steindorfer P, et al. Stöger H, et al. Among authors: bauernhofer t. Cancer Chemother Pharmacol. 1994;34(1):75-8. doi: 10.1007/BF00686116. Cancer Chemother Pharmacol. 1994. PMID: 8174206 Clinical Trial.
Combined treatment of metastatic osteosarcoma of the spine.
Bauernhofer T, Stöger H, Kasparek AK, Ploner F, Kuss I, Pieber TR, Kotz R, Samonigg H. Bauernhofer T, et al. Oncology. 1999 Nov;57(4):265-8. doi: 10.1159/000012058. Oncology. 1999. PMID: 10575309 Review.
[Therapy of castration-resistant prostate cancer].
Rauchenwald M, Bauernhofer T, De Santis M, Füreder T, Höltl W, Kramer G, Krause S, Loidl W, Oismüller R, Reissigl A, Schmeller N, Stackl W, Stoiber F, Krainer M. Rauchenwald M, et al. Among authors: bauernhofer t. Wien Klin Wochenschr. 2012 Aug;124(15-16):538-51. doi: 10.1007/s00508-012-0206-1. Epub 2012 Jul 20. Wien Klin Wochenschr. 2012. PMID: 22815001 German.
117 results